[go: up one dir, main page]

NO20034641L - Kontroll av fremgangsmatefuktighet for fremstilling av store, porose partikler - Google Patents

Kontroll av fremgangsmatefuktighet for fremstilling av store, porose partikler

Info

Publication number
NO20034641L
NO20034641L NO20034641A NO20034641A NO20034641L NO 20034641 L NO20034641 L NO 20034641L NO 20034641 A NO20034641 A NO 20034641A NO 20034641 A NO20034641 A NO 20034641A NO 20034641 L NO20034641 L NO 20034641L
Authority
NO
Norway
Prior art keywords
production
humidity control
particles
porous particles
approx
Prior art date
Application number
NO20034641A
Other languages
English (en)
Other versions
NO20034641D0 (no
Inventor
Donghao Chen
Richard P Batycky
Lloyd Johnston
Jeffrey Mintzes
Original Assignee
Penn State Res Found
Alkermes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25274976&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034641(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Penn State Res Found, Alkermes Inc filed Critical Penn State Res Found
Publication of NO20034641L publication Critical patent/NO20034641L/no
Publication of NO20034641D0 publication Critical patent/NO20034641D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Glanulating (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Silicon Compounds (AREA)

Abstract

Forstøvningstørkede partikler som har spesifiserte aerodynamiske karakteristikker, fremstilles ved å atomisere en væskemating og å bringe væskematingen i kontakt med en tørregass, for eksempel luft eller nitrogen. Fuktigheten i tørregassen reguleres til en verdi, uttrykt for eksempel som duggpunkt, som er kjent for å produsere partikler med en spesifisert densitet ved lett banking eller aerodynamisk diameter. Partikler som har en volum-median-geometrisk diameter større enn ca. 5 (jm og en densitet ved lett banking på mindre enn ca. 0,4 g/cmforetrekkes.
NO20034641A 2001-04-18 2003-10-17 Kontroll av fremgangsmåtefuktighet for fremstilling av store, poröse partikler NO20034641D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/837,620 US6848197B2 (en) 2001-04-18 2001-04-18 Control of process humidity to produce large, porous particles
PCT/US2002/012320 WO2002085326A2 (en) 2001-04-18 2002-04-17 Large, porous particles produced controlling humidity during a spray drying process

Publications (2)

Publication Number Publication Date
NO20034641L true NO20034641L (no) 2003-10-17
NO20034641D0 NO20034641D0 (no) 2003-10-17

Family

ID=25274976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034641A NO20034641D0 (no) 2001-04-18 2003-10-17 Kontroll av fremgangsmåtefuktighet for fremstilling av store, poröse partikler

Country Status (18)

Country Link
US (2) US6848197B2 (no)
EP (1) EP1379219B1 (no)
JP (1) JP4203564B2 (no)
CN (1) CN100522142C (no)
AT (1) ATE418326T1 (no)
AU (1) AU2002258865B2 (no)
CA (1) CA2439818C (no)
CY (1) CY1108803T1 (no)
DE (1) DE60230495D1 (no)
DK (1) DK1379219T3 (no)
ES (1) ES2318007T3 (no)
IL (2) IL157569A0 (no)
MX (1) MXPA03009561A (no)
NO (1) NO20034641D0 (no)
NZ (1) NZ527884A (no)
PL (1) PL371979A1 (no)
PT (1) PT1379219E (no)
WO (1) WO2002085326A2 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US6848197B2 (en) * 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
ES2415654T3 (es) 2001-11-20 2013-07-26 Civitas Therapeutics, Inc. Composiciones particuladas mejoradas para suministro pulmonar
PL372247A1 (en) 2002-02-01 2005-07-11 Pfizer Products Inc. Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
US7008644B2 (en) * 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
US20040197413A1 (en) * 2003-04-04 2004-10-07 Genteric, Inc. Spray dry coacervation systems and methods
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20060105051A1 (en) * 2004-11-18 2006-05-18 Blair Jackson Manufacture of particles for pulmonary drug delivery by carbon dioxide assisted nebulization
JP2008514648A (ja) * 2004-12-16 2008-05-08 アドバンスト インハレーション リサーチ，インコーポレイテッド 肺疾患のための組成物および方法
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
JP5244189B2 (ja) * 2007-09-24 2013-07-24 インハレイション・サイエンシズ・スウェーデン・エイビイ 乾燥製剤を製造するためのシステムおよび方法
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
TWI792140B (zh) 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
WO2011154014A1 (en) * 2010-06-11 2011-12-15 Gea Process Engineering A/S Controlled humidity drying
WO2014074797A1 (en) 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
TR201902687T4 (tr) 2013-03-15 2019-03-21 Pearl Therapeutics Inc İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.
WO2014178891A1 (en) 2013-04-30 2014-11-06 Otitopic Inc. Dry powder formulations and methods of use
US9993488B2 (en) 2014-02-20 2018-06-12 Otitopic Inc. Dry powder formulations for inhalation
MA40910A (fr) 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
KR101626675B1 (ko) * 2014-11-12 2016-06-01 엘지전자 주식회사 공기조화기 및 그 제어방법
EP4026568A1 (en) 2015-04-17 2022-07-13 CureVac Real Estate GmbH Lyophilization of rna
CA2984339A1 (en) 2015-05-01 2016-11-10 Civitas Therapeutics, Inc. Zolmitriptan powders for pulmonary delivery
CN107635587A (zh) 2015-05-20 2018-01-26 库瑞瓦格股份公司 包含长链rna的干燥粉末组合物
EP3297682B1 (en) 2015-05-20 2021-07-14 CureVac AG Dry powder composition comprising long-chain rna
KR20180052566A (ko) 2015-07-02 2018-05-18 키비타스 테라퓨틱스, 인코포레이티드. 폐 전달용 트립탄 분말
CH711362B1 (de) * 2015-07-29 2019-11-15 Tecan Schweiz Ag Steuergerät für relative Feuchtigkeit.
WO2018132822A1 (en) 2017-01-16 2018-07-19 Envirostar, Llc Dryer control systems and methods
ES2901875T3 (es) 2017-04-24 2022-03-24 Cocrystal Pharma Inc Derivados de la pirrolopirimidina útiles como inhibidores de la replicación del virus de la influenza
US11878023B2 (en) 2017-10-25 2024-01-23 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for delivering pharmaceutical agents
WO2019084292A1 (en) 2017-10-25 2019-05-02 Arizona Board Of Regents On Behalf Of The University Of Arizona COMPOSITIONS AND METHODS FOR ADMINISTERING PHARMACEUTICAL AGENTS
US11904054B2 (en) 2018-01-19 2024-02-20 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for delivering pharmaceutical agents
US12357631B2 (en) 2018-07-27 2025-07-15 Cocrystal Pharma, Inc. Pyrrolo[2,3-B]pyridin derivatives as inhibitors of influenza virus replication
CN113286793B (zh) 2018-09-10 2024-04-05 共结晶制药公司 吡咯并吡嗪和吡啶并三嗪类流感病毒复制抑制剂
IL282018B2 (en) 2018-10-17 2025-06-01 Cocrystal Pharma Inc Combinations of inhibitors of influenza virus replication
EP3887355A1 (en) 2018-11-26 2021-10-06 Cocrystal Pharma, Inc. Inhibitors of influenza virus replication
CA3138530A1 (en) 2019-04-29 2020-11-05 Insmed Incorporated Dry powder compositions of treprostinil prodrugs and methods of use thereof
WO2021188620A1 (en) 2020-03-17 2021-09-23 Cocrystal Pharma Inc. Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
WO2021206876A1 (en) 2020-04-10 2021-10-14 Cocrystal Pharma, Inc. Inhibitors of norovirus and coronavirus replication
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment
KR20240055745A (ko) 2021-08-03 2024-04-29 코크리스탈 파마, 아이엔씨. 코로나바이러스 억제제
WO2023150747A1 (en) 2022-02-07 2023-08-10 Insmed Incorporated Dry powder compositions of bedaquiline and salts and methods of use thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3495458A (en) 1967-11-20 1970-02-17 Pillsbury Co Continuous sampling gas testing apparatus for use in dusty atmospheres
US4422900A (en) 1981-11-25 1983-12-27 Olin Corporation Spray drying apparatus for available chlorine-containing compounds
AU7908791A (en) 1990-05-08 1991-11-27 Liposome Technology, Inc. Direct spray-dried drug/lipid powder composition
US5632100A (en) 1993-11-17 1997-05-27 Niro Holding A/S Process and a spray drying apparatus for producing an agglomerated powder
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5833647A (en) * 1995-10-10 1998-11-10 The Penn State Research Foundation Hydrogels or lipogels with enhanced mass transfer for transdermal drug delivery
US6022737A (en) 1995-11-02 2000-02-08 Amgen Inc. Formulations for non-viral in vivo transfection in the lungs
PT885002E (pt) * 1996-03-04 2011-07-14 Massachusetts Inst Technology Materiais e métodos para aumento da internalização celular
AUPN940796A0 (en) 1996-04-23 1996-05-16 F.H. Faulding & Co. Limited Taste masked pharmaceutical compositions
USRE37053E1 (en) * 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6254854B1 (en) * 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
IL142432A0 (en) * 1998-10-05 2002-03-10 Penn State Res Found Compositions and methods for enhancing receptor-mediated cellular internalization
CA2376937C (en) 1999-06-30 2009-01-06 Inhale Therapeutics Systems Inc. Spray drying process for preparing dry powders
JP2003507411A (ja) 1999-08-25 2003-02-25 アドバンスト インハレーション リサーチ，インコーポレイテッド 噴霧乾燥大多孔性粒子製剤
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
WO2001023821A1 (en) 1999-09-29 2001-04-05 Glaxo Group Limited Methods and systems for controlling evaporative drying processes using environmental equivalency
US6848197B2 (en) * 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles

Also Published As

Publication number Publication date
CA2439818A1 (en) 2002-10-31
US20030017113A1 (en) 2003-01-23
JP4203564B2 (ja) 2009-01-07
US20050058607A1 (en) 2005-03-17
CA2439818C (en) 2008-06-17
IL157569A (en) 2008-04-13
CN1503661A (zh) 2004-06-09
AU2002258865B2 (en) 2006-01-12
NZ527884A (en) 2006-02-24
EP1379219A2 (en) 2004-01-14
DE60230495D1 (de) 2009-02-05
HK1061654A1 (en) 2004-09-30
DK1379219T3 (da) 2009-03-23
US6848197B2 (en) 2005-02-01
ES2318007T3 (es) 2009-05-01
CN100522142C (zh) 2009-08-05
US7469488B2 (en) 2008-12-30
WO2002085326A2 (en) 2002-10-31
CY1108803T1 (el) 2012-05-23
IL157569A0 (en) 2004-03-28
PT1379219E (pt) 2009-03-24
EP1379219B1 (en) 2008-12-24
WO2002085326A3 (en) 2003-04-10
MXPA03009561A (es) 2004-02-12
NO20034641D0 (no) 2003-10-17
PL371979A1 (en) 2005-07-11
ATE418326T1 (de) 2009-01-15
JP2005508853A (ja) 2005-04-07

Similar Documents

Publication Publication Date Title
NO20034641L (no) Kontroll av fremgangsmatefuktighet for fremstilling av store, porose partikler
Easter et al. Binary homogeneous nucleation: Temperature and relative humidity fluctuations, nonlinearity, and aspects of new particle production in the atmosphere
Thoene et al. Absorption of atmospheric NO2 by spruce (Picea abies) trees: II. Parameterization of NO2 fluxes by controlled dynamic chamber experiments
Wang et al. CO2 fertilization system integrated with a low-cost direct air capture technology
DE602006008313D1 (de) Vorrichtung zur regulierung des gasmediums in einem container
WO2003070957A3 (en) Plant polypeptide production
Bermeo et al. Adsorption capacities of hygroscopic materials based on NaCl‐TiO2 and NaCl‐SiO2 core/shell particles
AU2002254553A1 (en) Epoxysilicone coated membranes
ATE496868T1 (de) Verfahren zur herstellung von siliciumdioxid aus olivin
CN107649100A (zh) 一种利用木质素制备水处理材料的方法
WO2006045081A3 (en) Predictive header pressure control
Stacey et al. Reduction in greenhouse water usage through inlet CO2 enrichment
CN200944110Y (zh) 温度稳定的温湿度检定箱
Jacobi et al. Influence of anthropogenic climate gas changes on the summer mesospheric/lower thermospheric meridional wind
Nishimoto et al. Assessment of control selection bias in a hospital-based case-control study of upper aero-digestive tract cancers
Appah EngineeringUse of triethylene glycol to dehydrate natural gas
ATE256094T1 (de) Verfahren zur trocknung von difluormethan
Zhamsueva et al. Spatio-temporal variability of atmospheric impurities over Lake Baikal during the expeditions to the SRV VA Koptyug in 2019
Shi et al. Carboxylation and Oxygenation Kinetics and Large Subunit (rbcL) DNA Sequences for Rubisco From Two Ecotypes of Plantago lanceolata L. That Are Native to Sites Differing in Atmospheric CO2 Levels
Piseri et al. Gas-Phase Nanoparticle Production, Handling and Separation by Aerodynamic Effects in Supersonic Expansion
Stark et al. Soil Moisture Regulates Microbial Carbon-use Efficiency in Soils of Different Textures
Ahn Determination of Optimal Hot Purge Gas Temperature in Regenerating Thermally an Air-Drying Zeolite 13X Column By Equilibrium Theory Analysis
Bobok et al. SORPTION OF CARBON DIOXIDE IN A FIXED BED OF THE MOLECULAR SIEVE CALSIT 5. I: VERIFICATION OF THE MODEL OF EQUILIBRIUM ADIABATIC SORPTION WITH THE MODIFIED LANGMUIR EQUATION
Hines Interactive effects of plant-community composition and elevated CO 2 on herbivore performance
Yakir et al. Experimental and numerical studies of the 18 O exchange between CO 2 and water in the soil--atmosphere exchange flux.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application